Skip to main content

BioDiscovery

Premium
BioDiscovery this week launched Nexus Copy Number Professional Version 3, a data integration tool that allows thousands of arrays along with their clinical annotations from any array platform, such as Agilent, Affymetrix, Illumina, Roche Nimblegen, and Empire Genomics, to be loaded and processed in a single project.
 
Additionally, version 3 enables the integration of external gene expression and miRNA results to any copy number analysis project allowing the scientist to overlay the data on regions of chromosomal aberrations, the company said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.